Lymphomatoid papulosis followed by Hodgkin's disease.
Silva
M M
MM
Department of Pathology, University Hospital, Federal University of Rio de Janeiro, Brazil.
Morais
J C
JC
Spector
N
N
Maceira
J
J
Sousa
M A
MA
Filgueira
A L
AL
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001761:Bleomycin / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D006689:Hodgkin Disease / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D006801:Humans; D017731:Lymphomatoid Papulosis / Q000150:complications / Q000188:drug therapy / Q000473:pathology*; D008297:Male; D009364:Neoplasm Recurrence, Local; D011701:PUVA Therapy; D011241:Prednisone / Q000627:therapeutic use; D011344:Procarbazine / Q000627:therapeutic use; D016539:Reed-Sternberg Cells / Q000473:pathology; D014747:Vinblastine / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D001761:Bleomycin; D011344:Procarbazine; D014750:Vincristine; D014747:Vinblastine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone